Berkeley Free Clinic (Berkeley Community Health Project)

Email

heptev@gmail.com

Phone

T: +1 510 548 2570 Ext.22

Web

http://www.berkeleyfreeclinic.org/

Address

2339 Durant Street, Berkeley, California CA United States of America
About Berkeley Free Clinic (Berkeley Community Health Project)

History

The Berkeley Free Clinic was founded in 1969 as a "street medicine" clinic that quickly found a niche and a permanent home in the Berkeley community. It has become an icon in the area, and has served countless thousands in a variety of ways during its 40-year history.

Fees have never been charged for any services, materials, medications or supplies provided at the Berkeley Free Clinic. Income has been generated solely via individual or organizational donations and government programs.

An emphasis on education, self-knowledge and an increasing awareness of appropriate resources infuses all of our medical, dental, counseling, and information/referral services. Direct services are provided almost exclusively by volunteer lay health care workers. Volunteers receive extensive and specific training in classroom and clinical settings. Whenever possible, our goal is to demystify health care and other human services, both for volunteers of the Clinic and for clients.

At the Berkeley Free Clinic, we treat each client with respect and dignity and view their needs within the larger context of their unique circumstances and access to resources. Treatments, referrals and guidance are provided in a client-centered context, and are appropriate to their lifestyle, culture, language and financial situation. We attempt to include clients as thoroughly as possible in their health care process.

Mission Statement

The mission of the Berkeley Free Clinic is to empower individuals and communities by providing accessible, client-centered health services and information.

Values

Healthcare is a right, not a privilege. Our approach to healthcare is guided by:

Respect
Demystification
Inclusivity
Collectivity
Vision

Vision

A community that is empowered to sustain its own health.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close